TP53 and cancer: The p53 core domain has 10 cysteine residues to which MQ can potentially bind and stabilize p53 wild-type conformation.1 Due to favorable molecular orbital interactions, high selectivity is achieved in comparison with classical hard electrophiles as the alkylating agents frequently used in cancer therapy.